Muscle Relaxants, Central

URI: https://gptkb.org/entity/Muscle_Relaxants,_Central

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:drug
gptkbp:actsOn	central nervous system
gptkbp:ATCCode	gptkb:M03BX
gptkbp:category	gptkb:centrally_acting_muscle_relaxants
gptkbp:cautionIn	elderly patients with hepatic impairment patients with history of substance abuse patients with renal impairment
gptkbp:commonHealthIssues	gptkb:baclofen gptkb:carisoprodol gptkb:cyclobenzaprine gptkb:methocarbamol gptkb:orphenadrine gptkb:tizanidine
gptkbp:compatibleWith	gptkb:myasthenia_gravis gptkb:acute_intermittent_porphyria
gptkbp:contraindication	hypersensitivity severe liver impairment
gptkbp:drugInteraction	gptkb:beer gptkb:CNS_depressants antidepressants
https://www.w3.org/2000/01/rdf-schema#label	Muscle Relaxants, Central
gptkbp:mechanismOfAction	depresses polysynaptic reflexes in the spinal cord
gptkbp:monitors	liver function mental status renal function
gptkbp:notToBeConfusedWith	gptkb:peripheral_muscle_relaxants
gptkbp:overdoseSymptoms	coma seizures respiratory depression
gptkbp:pregnancyCategory	varies by drug
gptkbp:prescriptionStatus	prescription only
gptkbp:regulates	approved in many countries
gptkbp:routeOfAdministration	oral intravenous
gptkbp:sideEffect	dizziness fatigue drowsiness weakness
gptkbp:usedFor	muscle spasms muscle spasticity
gptkbp:bfsParent	gptkb:D002409
gptkbp:bfsLayer	6